Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

Journal of Experimental Medicine

Volumn 205, Issue 2, 2008, Pages 373-383

  Mullick, Adam E ^a   Soldau, Katrin ^a   Kiosses, William B ^a   Bell III, Thomas A ^a   Tobias, Peter S ^a   Curtiss, Linda K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BONE MARROW; BONE MARROW CELL; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; FOAM CELL; HYPERLIPIDEMIA; LASER MICROSCOPY; LEUKOCYTE; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AORTA; ATHEROSCLEROSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DIET, ATHEROGENIC; ENDOTHELIAL CELLS; FEMALE; GREEN FLUORESCENT PROTEINS; HYPERLIPIDEMIAS; LEUKOCYTES; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; REGIONAL BLOOD FLOW; TOLL-LIKE RECEPTOR 2;

EID: 39549120661     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071096     Document Type: Article

References (26)

1. Steinberg, D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8:1211-1217.
2. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-126.
3. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
5. Hansson, G.K., A.-K.L. Robertson, and C. Soderberg-Naucler. 2006. Inflammation and atherosclerosis. Annu. Rev. Pathol. 1:297-329.
6. VanderLaan, P.A., C.A. Reardon, and G.S. Getz. 2004. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 24:12-22.
7. Dunzendorfer, S., H.K. Lee, and P.S. Tobias. 2004. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ. Res. 95:684-691.
8. Mullick, A.E., P.S. Tobias, and L.K. Curtiss. 2005. Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115:3149-3156.
9. Tzima, E., M. Irani-Tehrani, W.B. Kiosses, E. Dejana, D.A. Schultz, B. Engelhardt, G. Cao, H. DeLisser, and M.A. Schwartz. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 437:426-431.
10. Iiyama, K., L. Hajra, M. Iiyama, H. Li, M. DiChiara, B.D. Medoff, and M.I. Cybulsky. 1999. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85:199-207.
11. Greenspan, P., E.P. Mayer, and S.D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:965-973.
12. Tso, C., G. Martinic, W.H. Fan, C. Rogers, K.A. Rye, and P.J. Barter. 2006. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler. Thromb. Vasc. Biol. 26:1144-1149.
13. Nijhuis, M.M., G. Pasterkamp, N.I. Sluis, D.P. de Kleijn, J.D. Laman, and L.H. Ulfman. 2007. Peptidoglycan increases firm adhesion of monocytes under flow conditions and primes monocyte chemotaxis. J. Vasc. Res. 44:214-222.
14. Hajra, L., A.I. Evans, M. Chen, S.J. Hyduk, T. Collins, and M.I. Cybulsky. 2000. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. USA. 97:9052-9057.
15. Jongstra-Bilen, J., M. Haidari, S.N. Zhu, M. Chen, D. Guha, and M.I. Cybulsky. 2006. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203:2073-2083.
16. Edfeldt, K., J. Swedenborg, G.K. Hansson, and Z.Q. Yan. 2002. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 105:1158-1161.
17. Bobryshev, Y.V., and R.S. Lord. 1999. Accumulation of co-localised unesterified cholesterol and neutral lipids within vacuolised elastin fibres in athero-prone areas of the human aorta. Atherosclerosis. 142:121-131.
18. Nakashima, Y., H. Fujii, S. Sumiyoshi, T.N. Wight, and K. Sueishi. 2007. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage accumulation. Arterioscler. Thromb. Vasc. Biol. 27:1159-1165.
19. Simionescu, N., E. Vasile, F. Lupu, G. Popescu, and M. Simionescu. 1986. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol. 123:109-125.
20. Mullick, A.E., P.S. Tobias, and L.K. Curtiss. 2006. Toll-like receptors and atherosclerosis: key contributors in disease and health? Immunol. Res. 34:193-209.
21. Leemans, J.C., G. Stokman, N. Claessen, K.M. Rouschop, G.J. Teske, C.J. Kirschning, S. Akira, T. van der Poll, J.J. Weening, and S. Florquin. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115:2894-2903.
22. Favre, J., P. Musette, V. Douin-Echinard, K. Laude, J.P. Henry, J.F. Arnal, C. Thuillez, and V. Richard. 2007. Toll-Like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 27:1064-1071.
23. Sakata, Y., J.W. Dong, J.G. Vallejo, C.H. Huang, J.S. Baker, K.J. Tracey, O. Tacheuchi, S. Akira, and D.L. Mann. 2007. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 292:H503-H509.
24. Bjorkbacka, H., V.V. Kunjathoor, K.J. Moore, S. Koehn, C.M. Ordija, M.A. Lee, T. Means, K. Halmen, A.D. Luster, D.T. Golenbock, and M.W. Freeman. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10:416-421.
25. Shigeoka, A.A., T.D. Holscher, A.J. King, F.W. Hall, W.B. Kiosses, P.S. Tobias, N. Mackman, and D.B. McKay. 2007. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178:6252-6258.
26. Kiosses, W.B., N.H. McKee, and V.I. Kalnins. 1997. Evidence for the migration of rat aortic endothelial cells toward the heart. Arterioscler. Thromb. Vasc. Biol. 17:2891-2896.